318 related articles for article (PubMed ID: 25127846)
21. Contrast-enhanced spectral mammography in patients with MRI contraindications.
Richter V; Hatterman V; Preibsch H; Bahrs SD; Hahn M; Nikolaou K; Wiesinger B
Acta Radiol; 2018 Jul; 59(7):798-805. PubMed ID: 29058963
[TBL] [Abstract][Full Text] [Related]
22. Contrast-enhanced spectral mammography (CESM).
James JJ; Tennant SL
Clin Radiol; 2018 Aug; 73(8):715-723. PubMed ID: 29937340
[TBL] [Abstract][Full Text] [Related]
23. Contrast-enhanced spectral mammography (CESM) in women presenting with palpable breast findings.
Sorin V; Faermann R; Yagil Y; Shalmon A; Gotlieb M; Halshtok-Neiman O; Ben-David MA; Sklair-Levy M
Clin Imaging; 2020 May; 61():99-105. PubMed ID: 32014818
[TBL] [Abstract][Full Text] [Related]
24. Correlation between quantitative assessment of contrast enhancement in contrast-enhanced spectral mammography (CESM) and histopathology-preliminary results.
Rudnicki W; Heinze S; Niemiec J; Kojs Z; Sas-Korczynska B; Hendrick E; Luczynska E
Eur Radiol; 2019 Nov; 29(11):6220-6226. PubMed ID: 31089850
[TBL] [Abstract][Full Text] [Related]
25. Contrast-enhanced spectral mammography as work-up tool in patients recalled from breast cancer screening has low risks and might hold clinical benefits.
Houben IPL; Van de Voorde P; Jeukens CRLPN; Wildberger JE; Kooreman LF; Smidt ML; Lobbes MBI
Eur J Radiol; 2017 Sep; 94():31-37. PubMed ID: 28941757
[TBL] [Abstract][Full Text] [Related]
26. Contrast-Enhanced Spectral Mammography in Women With Intermediate Breast Cancer Risk and Dense Breasts.
Sorin V; Yagil Y; Yosepovich A; Shalmon A; Gotlieb M; Neiman OH; Sklair-Levy M
AJR Am J Roentgenol; 2018 Nov; 211(5):W267-W274. PubMed ID: 30240292
[TBL] [Abstract][Full Text] [Related]
27. Contrast-Enhanced Spectral Mammography is Comparable to MRI in the Assessment of Residual Breast Cancer Following Neoadjuvant Systemic Therapy.
Patel BK; Hilal T; Covington M; Zhang N; Kosiorek HE; Lobbes M; Northfelt DW; Pockaj BA
Ann Surg Oncol; 2018 May; 25(5):1350-1356. PubMed ID: 29516362
[TBL] [Abstract][Full Text] [Related]
28. Adding the power of iodinated contrast media to the credibility of mammography in breast cancer diagnosis.
Tsigginou A; Gkali C; Chalazonitis A; Feida E; Vlachos DE; Zagouri F; Rellias I; Dimitrakakis C
Br J Radiol; 2016 Nov; 89(1067):20160397. PubMed ID: 27452266
[TBL] [Abstract][Full Text] [Related]
29. Dual-Energy Contrast-Enhanced Spectral Mammography: Enhancement Analysis on BI-RADS 4 Non-Mass Microcalcifications in Screened Women.
Cheung YC; Juan YH; Lin YC; Lo YF; Tsai HP; Ueng SH; Chen SC
PLoS One; 2016; 11(9):e0162740. PubMed ID: 27611215
[TBL] [Abstract][Full Text] [Related]
30. Computer-aided diagnosis of contrast-enhanced spectral mammography: A feasibility study.
Patel BK; Ranjbar S; Wu T; Pockaj BA; Li J; Zhang N; Lobbes M; Zhang B; Mitchell JR
Eur J Radiol; 2018 Jan; 98():207-213. PubMed ID: 29279165
[TBL] [Abstract][Full Text] [Related]
31. Quantification of enhancement in contrast-enhanced spectral mammography using a custom-made quantifier tool (I-STRIP): A proof-of-concept study.
Lobbes MBI; Mulder HKP; Rousch M; Backes WH; Wildberger JE; Jeukens CRLPN
Eur J Radiol; 2018 Sep; 106():114-121. PubMed ID: 30150032
[TBL] [Abstract][Full Text] [Related]
32. Contrast-Enhanced Spectral Mammography Versus Ultrasonography: Diagnostic Performance in Symptomatic Patients with Dense Breasts.
Lu Z; Hao C; Pan Y; Mao N; Wang X; Yin X
Korean J Radiol; 2020 Apr; 21(4):442-449. PubMed ID: 32193892
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic accuracy of contrast-enhanced spectral mammography in comparison to conventional full-field digital mammography in a population of women with dense breasts.
Mori M; Akashi-Tanaka S; Suzuki S; Daniels MI; Watanabe C; Hirose M; Nakamura S
Breast Cancer; 2017 Jan; 24(1):104-110. PubMed ID: 26942415
[TBL] [Abstract][Full Text] [Related]
34. Contrast-enhanced spectral mammography (CESM) and contrast enhanced MRI (CEMRI): Patient preferences and tolerance.
Hobbs MM; Taylor DB; Buzynski S; Peake RE
J Med Imaging Radiat Oncol; 2015 Jun; 59(3):300-5. PubMed ID: 25900704
[TBL] [Abstract][Full Text] [Related]
35. [Retrospective analysis of a computer-aided detection (CAD) system in full-field digital mammography in correlation to tumor histology].
Obenauer S; Sohns C; Werner C; Grabbe E
Rofo; 2005 Aug; 177(8):1103-9. PubMed ID: 16021542
[TBL] [Abstract][Full Text] [Related]
36. Added Value of Contrast-Enhanced Spectral Mammography in Postscreening Assessment.
Tardivel AM; Balleyguier C; Dunant A; Delaloge S; Mazouni C; Mathieu MC; Dromain C
Breast J; 2016 Sep; 22(5):520-8. PubMed ID: 27345656
[TBL] [Abstract][Full Text] [Related]
37. Could parenchymal enhancement on contrast-enhanced spectral mammography (CESM) represent a new breast cancer risk factor? Correlation with known radiology risk factors.
Savaridas SL; Taylor DB; Gunawardana D; Phillips M
Clin Radiol; 2017 Dec; 72(12):1085.e1-1085.e9. PubMed ID: 28870431
[TBL] [Abstract][Full Text] [Related]
38. Breast tomosynthesis: Accuracy of tumor measurement compared with digital mammography and ultrasonography.
Förnvik D; Zackrisson S; Ljungberg O; Svahn T; Timberg P; Tingberg A; Andersson I
Acta Radiol; 2010 Apr; 51(3):240-7. PubMed ID: 20105090
[TBL] [Abstract][Full Text] [Related]
39. Contrast-enhanced spectral mammography vs. mammography and MRI - clinical performance in a multi-reader evaluation.
Fallenberg EM; Schmitzberger FF; Amer H; Ingold-Heppner B; Balleyguier C; Diekmann F; Engelken F; Mann RM; Renz DM; Bick U; Hamm B; Dromain C
Eur Radiol; 2017 Jul; 27(7):2752-2764. PubMed ID: 27896471
[TBL] [Abstract][Full Text] [Related]
40. Contrast-enhanced Spectral Mammography: Modality-Specific Artifacts and Other Factors Which May Interfere with Image Quality.
Bhimani C; Li L; Liao L; Roth RG; Tinney E; Germaine P
Acad Radiol; 2017 Jan; 24(1):89-94. PubMed ID: 27765597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
